Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05224336

Organisation Name: University of California, San Diego

Overal Status: Not yet recruiting

Start Date: March 1, 2022

Last Update: February 4, 2022

Lead Sponsor: University of California, San Diego

Brief Summary: This double-blind placebo-controlled pilot study seeks to investigate whether psilocybin can be safely administered to people with chronic phantom limb pain (PLP) in a supportive setting with close follow-up, and its effects on pain symptoms and other moods, attitudes, and behaviors. The investigators' primary hypotheses are that psilocybin is safe to administer in people with PLP and that it will reduce scores on measures of pain. The investigators will also assess a number of secondary measures related to the behavioral and neural responses to pain after psilocybin treatment.

Conditions:
  • Phantom Limb Pain


Total execution time in seconds: 0.24167203903198